We're launching new research funding grants to encourage new collaborations between researchers in the UK and US in the priority field of cancer early detection
Our Centre for Drug Development, working in partnerships with Bicycle Therapeutics, is trialing a first-in-class drug in patients with advanced solid tumours.
We're making it easier for exceptionally talented scientists and promising new researchers from outside the UK to join our research community.
In this article Professor Malcolm Stevens reflects on the work that led to his team’s discovery of temozolomide.
Our scientists have been at the forefront of PARP inhibitor research and development. Here we share the story of rucaparib.